Cool it, analyst urges ‘overly punitive’ BMS investors after rough Opdivo week
admin 23rd October 2018 Uncategorised 0There’s no denying that Bristol-Myers Squibb’s Opdivo has had a tough week, and the company’s stock suffered a 6% hit Monday morning. But the way one analyst sees it, investors are overreacting.
More: Cool it, analyst urges ‘overly punitive’ BMS investors after rough Opdivo week
Source: fierce